620 related articles for article (PubMed ID: 29281578)
1. Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets.
Zeiser R; Blazar BR
N Engl J Med; 2017 Dec; 377(26):2565-2579. PubMed ID: 29281578
[No Abstract] [Full Text] [Related]
2. Ocular graft-versus-host disease: a review.
Shikari H; Antin JH; Dana R
Surv Ophthalmol; 2013; 58(3):233-51. PubMed ID: 23541042
[TBL] [Abstract][Full Text] [Related]
3. Chronic graft-vs-host disease.
Bhushan V; Collins RH
JAMA; 2003 Nov; 290(19):2599-603. PubMed ID: 14625337
[No Abstract] [Full Text] [Related]
4. [Treatment of chronic graft-versus-host disease with protein tyrosine kinase inhibitors].
Martínez C
Methods Find Exp Clin Pharmacol; 2010 Dec; 32 Suppl A():69-71. PubMed ID: 21381292
[TBL] [Abstract][Full Text] [Related]
5. Malar rash in a stem cell transplant recipient.
Mansh M; Johnson W; Lai J
JAMA; 2014 Aug; 312(5):547-8. PubMed ID: 25096696
[No Abstract] [Full Text] [Related]
6. Edema with hypoalbuminemia as a rare manifestation of chronic graft versus host disease after allogeneic hematopoietic cell transplant.
Hogan JJ; Loren AW; Denker MG; Mangan JK
Leuk Lymphoma; 2017 Aug; 58(8):2008-2010. PubMed ID: 27998198
[No Abstract] [Full Text] [Related]
7. Long-term efficacy of topical tacrolimus on oral lesions of chronic graft-versus-host disease.
Fricain JC; Sibaud V; Swetyenga N; Tabrizi R; Campana F; Taïeb A
Br J Dermatol; 2007 Mar; 156(3):588-90. PubMed ID: 17300261
[No Abstract] [Full Text] [Related]
8. Oral chronic graft-versus-host disease: current pathogenesis, therapy, and research.
Mays JW; Fassil H; Edwards DA; Pavletic SZ; Bassim CW
Oral Dis; 2013 May; 19(4):327-46. PubMed ID: 23107104
[TBL] [Abstract][Full Text] [Related]
9. IL-35 inhibits acute graft-versus-host disease in a mouse model.
Zhang XH; Zhou Y; Zhang JM; Zhou SY; Wang M; Feng R; Feng FE; Wang QM; Zhu XL; Zhao XS; Lv M; Kong Y; Chang YJ; Huang XJ
Int Immunopharmacol; 2015 Dec; 29(2):383-392. PubMed ID: 26507167
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine and methotrexate-related pharmacogenomic predictors of acute graft-versus-host disease.
Laverdière I; Guillemette C; Tamouza R; Loiseau P; Peffault de Latour R; Robin M; Couture F; Filion A; Lalancette M; Tourancheau A; Charron D; Socié G; Lévesque É
Haematologica; 2015 Feb; 100(2):275-83. PubMed ID: 25425682
[TBL] [Abstract][Full Text] [Related]
11. Acquired ichthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia.
Dilek I; Demirer T; Ustün C; Arat M; Koç H; Beksaç M; Erdi H; Anadolu R; Ozcan M; Ilhan O; Akan H
Bone Marrow Transplant; 1998 Jun; 21(11):1159-61. PubMed ID: 9645582
[TBL] [Abstract][Full Text] [Related]
12. Peripheral Blood CD38 Bright CD8+ Effector Memory T Cells Predict Acute Graft-versus-Host Disease.
Khandelwal P; Lane A; Chaturvedi V; Owsley E; Davies SM; Marmer D; Filipovich AH; Jordan MB; Marsh RA
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1215-22. PubMed ID: 25881755
[TBL] [Abstract][Full Text] [Related]
13. Understanding graft-versus-host disease. Preliminary findings regarding the effects of exercise in affected patients.
Fiuza-Luces C; Garatachea N; Simpson RJ; Berger NA; Ramírez M; Lucia A
Exerc Immunol Rev; 2015; 21():80-112. PubMed ID: 25826127
[TBL] [Abstract][Full Text] [Related]
14. Chronic graft versus host disease of oral mucosa: review of available therapies.
Imanguli MM; Pavletic SZ; Guadagnini JP; Brahim JS; Atkinson JC
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Feb; 101(2):175-83. PubMed ID: 16448918
[TBL] [Abstract][Full Text] [Related]
15. Prevention of chronic GVHD.
Lee JW; Deeg HJ
Best Pract Res Clin Haematol; 2008 Jun; 21(2):259-70. PubMed ID: 18503991
[TBL] [Abstract][Full Text] [Related]
16. [Methotrexate treatment in severe chronic ocular graft versus host disease (GvHD)].
Sabti S; Halter JP; Bosch MM; Goldblum D
Klin Monbl Augenheilkd; 2013 Apr; 230(4):344-5. PubMed ID: 23629775
[No Abstract] [Full Text] [Related]
17. Graft-versus-host disease after an infection by Rickettsia conorii induced by a tick's bite.
Torrent A; Ferrá C; Ribera JM
Med Clin (Barc); 2019 Feb; 152(3):119-120. PubMed ID: 29729935
[No Abstract] [Full Text] [Related]
18. Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant.
Vogelsang GB; Lee L; Bensen-Kennedy DM
Annu Rev Med; 2003; 54():29-52. PubMed ID: 12359826
[TBL] [Abstract][Full Text] [Related]
19. Novel immunosuppression compounds and experimental therapies for chronic graft-versus-host disease.
Michael M; Shimoni A; Nagler A
Acta Haematol; 2013; 130(1):34-43. PubMed ID: 23392110
[TBL] [Abstract][Full Text] [Related]
20. Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus.
Eckardt A; Starke O; Stadler M; Reuter C; Hertenstein B
Oral Oncol; 2004 Sep; 40(8):811-4. PubMed ID: 15288836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
